DUBLIN - Medtronic plc today announced U.S. Food and Drug Administration (FDA) clearance and commercial launch for the SelectSite(TM) C304-HIS deflectable catheter system for use in procedures ...

Please provide your email address to receive an email when new articles are posted on . Medtronic announced it has received FDA clearance for a deflectable catheter system used for His-bundle pacing ...

Medtronic plc MDT recently announced the FDA clearance for SelectSite C304-HIS deflectable catheter system and its market launch. The system will be used in procedures that involve His-bundle pacing ( ...

A recent study published in Pacing and Clinical Electrophysiology (PACE) determined that the use of catheter ablation to treat supraventricular tachycardia (SVT) is not detrimental to patients. This ...

Ying-Wei Chen, M.D.; Rong Bai, M.D.; Tao Lin, M.D.; Mohamed Salim, M.D.; Cai-Hua Sang, M.D.; De-Yong Long, M.D.; Rong-Hui Yu, M.D.; Ri-Bo Tang, M.D.; Xue-Yuan Guo, M ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a stylet-driven lead and delivery catheter system for left bundle branch area pacing Approval ...

Peter Spector, M.D.; Nicole Habel, M.D. With H and V-capture there is a combination of these findings. Local V activation is early, QRS onset is early, and QRS end is also early. The QRS duration is ...

Ventricular tachycardia arises from an abnormal electrical focus or circuit in the myocardium of the ventricle and is usually manifested as a tachyarrhythmia with a wide QRS complex on ...